# FDA Inspection 921003 - Cipla Limited - February 27, 2015

Source: https://www.keypedia.com/records/fda_inspections/cipla-limited/7321e401-7620-4ba5-87d4-c854b83e1edd
Source feed: FDA_Inspections

> FDA Inspection 921003 for Cipla Limited on February 27, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 921003
- Company Name: Cipla Limited
- Inspection Date: 2015-02-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1235546 - 2024-04-04](https://www.keypedia.com/records/fda_inspections/cipla-limited/65af85a2-5900-4582-bb2a-7cecc575b2dd)
- [FDA Inspection 1112254 - 2019-11-13](https://www.keypedia.com/records/fda_inspections/cipla-limited/296e8d60-0c37-4930-9cfa-39886c13f50d)
- [FDA Inspection 1033982 - 2017-12-06](https://www.keypedia.com/records/fda_inspections/cipla-limited/06ea161d-ed72-4ad7-9a20-d92c38704a1e)
- [FDA Inspection 953633 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/cipla-limited/79487881-4e11-4313-9216-d261b9c9761c)
- [FDA Inspection 796510 - 2012-06-06](https://www.keypedia.com/records/fda_inspections/cipla-limited/568299a8-b183-4ce7-8ab9-ed75b9a0e2b3)

Company: https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c